Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 57.50 GBp
Change Today 0.00 / 0.00%
Volume 0.0
RXB On Other Exchanges
Symbol
Exchange
London
As of 11:35 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

rex bionics plc (RXB) Snapshot

Open
57.50 GBp
Previous Close
57.50 GBp
Day High
57.50 GBp
Day Low
57.50 GBp
52 Week High
08/11/14 - 181.50 GBp
52 Week Low
06/11/15 - 56.50 GBp
Market Cap
8.2M
Average Volume 10 Days
1.7K
EPS TTM
-0.63 GBp
Shares Outstanding
14.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for REX BIONICS PLC (RXB)

Related News

No related news articles were found.

rex bionics plc (RXB) Related Businessweek News

No Related Businessweek News Found

rex bionics plc (RXB) Details

Rex Bionics Plc develops and manufactures hands-free robotic exoskeletons for use by wheelchair users in New Zealand. The company offers REX Rehab for use in rehabilitation centers and hospitals; and REX Personal for individual’s specific medical and physical requirements to perform tasks and functions. It sells its products in North America, Europe, and the Asia Pacific. The company was formerly known as Union MedTech plc and changed its name to Rex Bionics Plc in March 2012. Rex Bionics Plc was incorporated in 2007 and is based in North Shore City, New Zealand.

Founded in 2007

rex bionics plc (RXB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

rex bionics plc (RXB) Key Developments

Rex Bionics Plc Proposes Amendments to Articles of Association

Rex Bionics Plc at its General Meeting to be held on June 30, 2015, proposed Amendments to Articles of Association.

Rex Bionics Plc, Special/Extraordinary Shareholders Meeting, Jun 30, 2015

Rex Bionics Plc, Special/Extraordinary Shareholders Meeting, Jun 30, 2015., at 10:00 GMT Standard Time. Location: offices of Simmons & Simmons. Agenda: To consider each of the existing issued ordinary shares of £1 each in the share capital of the company is sub-divided and re-designated into one new ordinary share of 10 pence and one new deferred share of 90 pence in the share capital of the company; and to consider Articles of Association be amended by the addition of a new definition to Article 2.1 and a new Article 5.2 setting out the rights of the deferred shares.

Rex Bionics plc Announces the First Patient Treated in Rapper II Clinical Trial

Rex Bionics Plc announced that the first patient has been successfully treated in its RAPPER II (Robot-Assisted PhysiotheraPy Exercises with REX) clinical trial. RAPPER II is a 100 patient study designed to measure time taken for wheelchair users to mobilise in a REX, exercise regimen completion and the severity of injury that can safely be treated with a REX. The participants are wheelchair users with a spinal cord injury.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RXB:LN 57.50 GBp 0.00

RXB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CYBERDYNE Inc ¥1,531 JPY +17.00
Ekso Bionics Holdings Inc $1.03 USD 0.00
Parker-Hannifin Corp $112.75 USD +0.17
ReWalk Robotics Ltd $10.52 USD +0.18
View Industry Companies
 

Industry Analysis

RXB

Industry Average

Valuation RXB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REX BIONICS PLC, please visit www.rexbionics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.